Frontiers in Cardiovascular Medicine

MARCH 12, 2024

Cardiogenic shock (CS) is a time-sensitive and hemodynamically complex syndrome with a broad spectrum of etiologies and clinical presentations. Despite contemporary therapies, CS continues to maintain high morbidity and mortality ranging from 35 to 50%. More recently, burgeoning observational research in this field aimed at enhancing the early recognition and characterization of the shock state through standardized team-based protocols, comprehensive hemodynamic profiling, and tailored and selec

Cardiogenic Shock 145

Cardiogenic Shock Pharmacology Outcomes Research 145

HCPLive

MARCH 12, 2024

Eiran Gorodeski, MD, MPH, discusses a recent scientific statement composed on behalf of the Heart Failure Society of America highlighting the impact of cognitive impairment on patients with heart failure.

Heart Failure 75

Heart Failure 75

Frontiers in Cardiovascular Medicine

MARCH 12, 2024

Cardiovascular mortality is still excessively high, despite the considerable progress made in the prevention and treatment of cardiovascular diseases. Although many cardiovascular risk factors (such as arterial hypertension, hypercholesterolemia, diabetes, etc.), identified in the general population, are being promptly treated, to date little consideration is given to a cardiovascular risk factor which we believe has largely demonstrated in the scientific literature of the last three decades tha

Risk Factors 105

Risk Factors Article Cardiovascular Disease Diabetes 105

JAMA Cardiology

MARCH 12, 2024

This randomized clinical trial compares 12-month event rates using quantitative coronary angiography guidance during percutaneous coronary intervention with those after intravascular ultrasonography–guided stent implantation.

Stents 71

Stents Stent 71

Nature Reviews - Cardiology

MARCH 12, 2024

Nature Reviews Cardiology, Published online: 13 March 2024; doi:10.1038/s41569-024-01006-0 In this Tools of the Trade article, Olivera describes a rat model of pre-elampsia that has been instrumental for investigating potential long-term cardiovascular effects in offspring.

Article 59

Article 59

Frontiers in Cardiovascular Medicine

MARCH 12, 2024

Intraluminal thrombus formation (ILT) is a recently discovered and highly clinically relevant complication after frozen elephant trunk implantation in cardiovascular surgery. In this phenomenon, a thrombus forms within the lumen of the stent graft component of the frozen elephant trunk prosthesis and puts the patient at risk for downstream embolization with visceral or lower limb ischemia.

Stents 59

Stents Stent Risk Factors Thrombosis 59

HCPLive

MARCH 12, 2024

A greater patient-to-patient care technician ratio was associated with increased mortality and hospitalization with lower rates of waitlisting and transplantation among patients receiving in-center hemodialysis.

Patient Care 59

Patient Care Transplant Outcomes Hospital 59

American College of Cardiology

MARCH 12, 2024

The goal of the DISCHARGE trial was to evaluate computed tomography (CT) compared with invasive coronary angiography among patients with stable chest pain and intermediate pretest probability of obstructive coronary artery disease.

Coronary Artery Disease 65

Coronary Artery Disease Chest Pain Article 65

HCPLive

MARCH 12, 2024

The 2016 CDC guidelines led to significant decreases in opioid prescriptions and an increase in pain-related healthcare utilization for people with sickle cell disease.

Sickle Cell Disease 59

Sickle Cell Disease 59

Becker's Hospital Review - Cardiology

MARCH 12, 2024

Discover the lifestyle of cardiologists: from exercise habits to work-life balance, a recent Medscape survey reveals insights on this specialty's well-being.

Exercise 59

Exercise 59

HCPLive

MARCH 12, 2024

The phase 3 ENLIGHTEN program will consist of 2 phase 3 trials evaluating the safety and efficacy of pegozafermin in patients with MASH.

64

64

American College of Cardiology

MARCH 12, 2024

In this interview, Adam J. Milam, MD, PhD, and Clyde W.Yancy, MD, MSc, MACC, discuss the JACC State-of-the-Art Review: Racial and Ethnic Disparities in Perioperative Health Care Among Patients Undergoing Cardiac Surgery.

Article 60

Article 60

HCPLive

MARCH 12, 2024

An analysis of an FDA adverse event database found thrombotic adverse events were more frequently reported with emicizumab than those of FVIII products.

59

59

Journal of Cardiothoracic Surgery

MARCH 12, 2024

Ultrasound-guided percutaneous axillary vein cannulation can reduce cannulation failure and mechanical complications, is as safe and effective as internal jugular vein cannulation, and is superior to subclavia.

Ultrasound 52

Ultrasound 52

HCPLive

MARCH 12, 2024

Acadia Pharmaceuticals decided to stop conducting further clinical trials with pimavanserin for negative symptoms of negative due to topline results.

59

59

Journal of Cardiothoracic Surgery

MARCH 12, 2024

Acute type A aortic intramural hematoma (ATAIMH) is a variant of acute type A aortic dissection (ATAAD), exhibiting an increased risk of hemopericardium and cardiac tamponade. It can be life-threatening withou.

Aortic 52

Aortic Outcomes Research 52

DAIC

MARCH 12, 2024

Getinge has announced the U.S. Food and Drug Administration’s (FDA) 510(k) clearance of the Vasoview Hemopro 3, the latest addition to the medtech company’s endoscopic vessel harvesting (EVH) solutions. Image courtesy: Getinge christine.book Tue, 03/12/2024 - 11:41 March 12, 2024 — Getinge has announced the U.S. Food and Drug Administration ’s ( FDA ) 510(k) clearance of the Vasoview Hemopro 3, the latest addition to the medtech company’s endoscopic vessel harvesting (EVH) solutions.

Innovation 52

Innovation Research Outcomes 52

HCPLive

MARCH 12, 2024

New global data suggest children with moderate to severe atopic dermatitis may experience stunted growth due to the effect of their disease on sleep, as well as use of certain therapies.

52

52

DAIC

MARCH 12, 2024

Physicians at Vilnius University Hospital. milla1cf Tue, 03/12/2024 - 16:44 March 12, 2024 — Stereotaxis , a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, announced that regulatory submissions were made recently in both Europe and the United States for the MAGiC catheter. These submissions follow successful initial clinical results in an ongoing trial.

Ablation 52

Ablation Electrophysiology Document Innovation 52

Med Page Today

MARCH 12, 2024

(MedPage Today) -- The FDA announced the class I recall of an Abbott app used to monitor patients using the HeartMate 3 Left Ventricular Assist Device (LVAD), as well as updated guidance related to the troublesome "Stop Pump" command; the recall.

52

52

DAIC

MARCH 12, 2024

milla1cf Tue, 03/12/2024 - 16:48 March 12, 2024 — Medtronic plc , a global leader in healthcare technology, today announced two late-breaking data presentations on four-year outcomes from the Evolut Low Risk Trial. A cost-effectiveness analysis demonstrates the positive economic value of transcatheter aortic valve replacement (TAVR) using Evolut TAVR compared to surgical aortic valve replacement (SAVR) for low-risk patients.

TAVR 52

TAVR Aortic valve Aortic Stenosis 52

The American Journal of Cardiology

MARCH 12, 2024

Publication date: Available online 12 March 2024 Source: The American Journal of Cardiology Author(s): Masaharu Masuda, Yasuhiro Matsuda, Hiroyuki Uematsu, Mitsutoshi Asai, Shin Okamoto, Takayuki Ishihara, Kiyonori Nanto, Takuya Tsujimura, Yosuke Hata, Naoko Higashino, Sho Nakao, Toshiaki Mano

Atrial Fibrillation 52

Atrial Fibrillation Pulmonary 52

DAIC

MARCH 12, 2024

The U.S. Food and Drug Administration (FDA) announced that Abbott is recalling its HeartMate Touch System (version 1.0.32) for risk of unexpected pump stop or start. Issues may occur if the HeartMate Touch System is disconnected from a patient’s HeartMate Controller while a “pump stop” command is running. People who have the implantable HeartMate 3 Left Ventricular Assist Device may be affected. christine.book Tue, 03/12/2024 - 09:40 March 12, 2024 — The U.S.

Hospital 52

Hospital 52

Heart BMJ

MARCH 12, 2024

Objective To investigate whether a very early invasive strategy (IS)±revascularisation improves clinical outcomes compared with standard care IS in higher risk patients with non-ST-elevation acute coronary syndrome (NSTE-ACS). Methods Multicentre, randomised, controlled, pragmatic strategy trial of higher risk patients with NSTE-ACS, defined by Global Registry of Acute Coronary Events 2.0 score of ≥118, or ≥90 with at least one additional high-risk feature.

COVID-19 52

COVID-19 Myocardial Infarction Heart Failure Outcomes 52

HCPLive

MARCH 12, 2024

Alexis spoke in this AAD interview about his team’s results regarding lebrikizumab for adults and adolescents with moderate-to-severe atopic dermatitis and skin of color.

52

52

Heart BMJ

MARCH 12, 2024

Introduction Takotsubo syndrome (TTS) is an acute heart failure syndrome, featured by transient left ventricular systolic dysfunction. Recurrences of TTS are not infrequent and there is no standard preventive therapy. The aim of this study was to evaluate in a network meta-analysis if beta-blockers (BB) and ACE inhibitors/angiotensin receptor blockers (ACEi/ARBs), in combination or not, can effectively prevent TTS recurrences.

ACE Inhibitor 52

ACE Inhibitor Heart Failure Outcomes 52

HCPLive

MARCH 12, 2024

Blauvelt discusses the future research of higher-dose risankizumab for patients with psoriasis—and why it may be "disruptive in the treatment space.

Research 52

Research 52

Heart BMJ

MARCH 12, 2024

In this issue of Heart, Castelijns et al aimed to apply the inclusion and exclusion criteria from the Cardiovascular Outcomes for People Using Anticoagulation Strategies, Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance trials, Prevention of Cardiovascular Events in Patients with Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction and Dual Antiplatelet Therapy to patients included

Peripheral Arterial Disease 52

Peripheral Arterial Disease Myocardial Infarction Heart Attack Heart attacks 52

HCPLive

MARCH 12, 2024

Both biologic-naïve and biologic-experience patients receiving guselkumab demonstrated significantly higher ACR20 when compared with ustekinumab.

52

52

American College of Cardiology

MARCH 12, 2024

What are the trends in the estimated prevalence of underweight and obesity from 1990 to 2022 among adults and children across 200 countries and territories?

Obesity 53

Obesity Article 53

HCPLive

MARCH 12, 2024

Study links childhood amblyopia with increased risk of cardiometabolic dysfunction in adulthood.

64

64

Becker's Hospital Review - Cardiology

MARCH 12, 2024

Houston-based Memorial Hermann Health System and Memorial Hermann Foundation renamed the system's heart institute after the late real estate entrepreneur Larry Johnson.

49

49

HCPLive

MARCH 12, 2024

These data presented at AAD 2024 highlight deuruxolitinib’s efficacy in the treatment of adults with moderate-to-severe alopecia areata.

52

52

HeartRhythm

MARCH 12, 2024

We are diagnosing atrial fibrillation (AF) more often that at any time in history. This is driven by the aging of our populations, the growing prevalence of AF risk factors and by the proliferation of longer-term electrocardiographic monitoring, including patient-facing technologies 1,2. However, one of medicine’s great triumphs of the last 30 years has been the ability to prevent most AF-related strokes.

Atrial Fibrillation 45

Atrial Fibrillation Stroke Strokes Risk Factors 45

HCPLive

MARCH 12, 2024

A new study found women (1.64) had a greater hazard ratio of depression for CVD than men (1.39).

59

59

American College of Cardiology

MARCH 12, 2024

The following are key points to remember from an American Heart Association Scientific Statement on cardiogenic shock (CS) in older adults, which focuses on age-associated risks and approach to management.

Cardiogenic Shock 45

Cardiogenic Shock Article 45

HCPLive

MARCH 12, 2024

Participants with RA had a 1.66-fold greater risk of depression compared to participants without RA, a new study found.

52

52